Long non-coding RNA UCA1 promotes breast tumor growth by suppression of p27 (Kip1).

作者: J Huang , N Zhou , K Watabe , Z Lu , F Wu

DOI: 10.1038/CDDIS.2013.541

关键词:

摘要: Functional genomics studies have led to the discovery of a large amount non-coding RNAs from human genome; among them are long (lncRNAs). Emerging evidence indicates that lncRNAs could critical role in regulation cellular processes such as cell growth and apoptosis well cancer progression metastasis. As master gene regulators, capable forming lncRNA–protein (ribonucleoprotein) complexes regulate number genes. For example, lincRNA-RoR suppresses p53 response DNA damage through interaction with heterogeneous nuclear ribonucleoprotein I (hnRNP I). The present study demonstrates hnRNP can also form functional complex lncRNA urothelial carcinoma-associated 1 (UCA1) increase UCA1 stability. Of interest, phosphorylated I, predominantly cytoplasm, is responsible for UCA1. Moreover, although enhances translation p27 (Kip1) 5′-untranslated region (5′-UTR) mRNAs, protein level by competitive inhibition. In support this finding, has an oncogenic breast both vitro vivo. Finally, we show negative correlation between UCA tumor tissue microarray. Together, our results suggest important cancer.

参考文章(48)
Lane Dp, Iggo R, Bartek J, Gannon J, Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines. Oncogene. ,vol. 5, pp. 893- 899 ,(1990)
Masatoshi Takagi, Michael J. Absalon, Kevin G. McLure, Michael B. Kastan, Regulation of p53 Translation and Induction after DNA Damage by Ribosomal Protein L26 and Nucleolin Cell. ,vol. 123, pp. 49- 63 ,(2005) , 10.1016/J.CELL.2005.07.034
L. Hengst, S. I. Reed, Translational control of p27Kip1 accumulation during the cell cycle. Science. ,vol. 271, pp. 1861- 1864 ,(1996) , 10.1126/SCIENCE.271.5257.1861
Sehwan Han, Kyeongmee Park, Hong‐Yong Kim, Myung‐Soo Lee, Hong‐Joo Kim, Young‐Duck Kim, Reduced expression of p27Kip1 protein is associated with poor clinical outcome of breast cancer patients treated with systemic chemotherapy and is linked to cell proliferation and differentiation. Breast Cancer Research and Treatment. ,vol. 55, pp. 161- 167 ,(1999) , 10.1023/A:1006258222233
Charles Catzavelos, Nandita Bhattacharya, Yee C. Ung, James A. Wilson, Luba Roncari, Charanjit Sandhu, Patricia Shaw, Herman Yeger, Isabella Morava-Protzner, Linda Kapusta, Edmée Franssen, Kathleen I. Pritchard, Joyce M. Slingerland, Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer. Nature Medicine. ,vol. 3, pp. 227- 230 ,(1997) , 10.1038/NM0297-227
Kornelia Polyak, Mong-Hong Lee, Hediye Erdjument-Bromage, Andrew Koff, James M. Roberts, Paul Tempst, Joan Massagué, Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals Cell. ,vol. 78, pp. 59- 66 ,(1994) , 10.1016/0092-8674(94)90572-X
Linda Tillmar, Carina Carlsson, Nils Welsh, Control of Insulin mRNA Stability in Rat Pancreatic Islets REGULATORY ROLE OF A 3′-UNTRANSLATED REGION PYRIMIDINE-RICH SEQUENCE Journal of Biological Chemistry. ,vol. 277, pp. 1099- 1106 ,(2002) , 10.1074/JBC.M108340200
Carlos le Sage, Remco Nagel, Reuven Agami, Diverse ways to control p27Kip1 function: miRNAs come into play. Cell Cycle. ,vol. 6, pp. 2742- 2749 ,(2007) , 10.4161/CC.6.22.4900
Shuhei Kotoshiba, Takumi Kamura, Taichi Hara, Noriko Ishida, Keiichi I. Nakayama, Molecular Dissection of the Interaction between p27 and Kip1 Ubiquitylation-promoting Complex, the Ubiquitin Ligase That Regulates Proteolysis of p27 in G1Phase Journal of Biological Chemistry. ,vol. 280, pp. 17694- 17700 ,(2005) , 10.1074/JBC.M500866200